Addex Therapeutics Ltd Expense Relating To Shortterm Leases For Which Recognition Exemption Has Been Used
Addex Therapeutics Ltd (ADXN) reported Expense Relating To Shortterm Leases For Which Recognition Exemption Has Been Used of CHF 1.54 thousand for the 3-month period ending 2024-06-30, per its 6-K filed 2025-09-30.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed · last filed 2025-09-30
- Addex Therapeutics Ltd expense relating to shortterm leases for which recognition exemption has been used for the quarter ending 2024-06-30 was 1.54K CHF, a 84.97% decline year-over-year.
- Addex Therapeutics Ltd expense relating to shortterm leases for which recognition exemption has been used for the quarter ending 2023-06-30 was 10.28K CHF, a 29.58% decline year-over-year.
- Addex Therapeutics Ltd expense relating to shortterm leases for which recognition exemption has been used for the quarter ending 2022-06-30 was 14.60K CHF, a 81.41% increase year-over-year.
- Addex Therapeutics Ltd expense relating to shortterm leases for which recognition exemption has been used for the quarter ending 2021-06-30 was 8.05K CHF.
| Period end | Expense Relating To Shortterm Leases For Which Recognition Exemption Has Been Used 3 month | Expense Relating To Shortterm Leases For Which Recognition Exemption Has Been Used 6 month | Expense Relating To Shortterm Leases For Which Recognition Exemption Has Been Used 12 month |
|---|---|---|---|
| 2024-06-30 | 1.54K CHF 6-K · filed 2025-09-30 | 1.54K CHF 6-K · filed 2025-09-30 | |
| 2023-12-31 | 35.57K CHF 20-F · filed 2024-04-18 | ||
| 2023-06-30 | 10.28K CHF 6-K/A · filed 2023-12-21 | 18.50K CHF 6-K/A · filed 2023-12-21 | |
| 2022-12-31 | 47.28K CHF 20-F · filed 2024-04-18 | ||
| 2022-06-30 | 14.60K CHF 6-K/A · filed 2023-12-21 | 27.86K CHF 6-K/A · filed 2023-12-21 | |
| 2021-12-31 | 37.51K CHF 20-F · filed 2024-04-18 | ||
| 2021-06-30 | 8.05K CHF 6-K/A · filed 2022-09-14 | 16.44K CHF 6-K/A · filed 2022-09-14 | |
| 2020-12-31 | 36.65K CHF 20-F · filed 2023-03-30 | ||
| 2019-12-31 | 26.15K CHF 20-F · filed 2022-03-10 | ||
| 2018-12-31 | 179.10K CHF 20-F · filed 2021-03-11 |